Clinical Trial Update: Frontline Clinician Psilocybin Study [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating psilocybin for burnout in frontline clinicians has completed, with results posted in 2025. The study also explored effects on depressio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burnout
• Major Depressive Disorder
• Moral Injury
• Post-traumatic Stress Disorder

Drugs mentioned

• Psilocybin (psilocybin)

Snippet

Sponsor: University of Washington | Conditions: Burnout, Caregiver, Burnout, Professional | Phase 3 | Status: COMPLETED | Results posted: 2025-03-18